Q1FY27 results: Revenue up 28%, PAT up 27%, Rs 368 Cr capex announced
HSCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Consolidated Q1FY27: Revenue from operations at Rs 1,431.88 Cr, up 28% YoY from Rs 1,118.29 Cr. Net profit rose 27% YoY to Rs 228.43 Cr vs Rs 179.36 Cr. EPS at Rs 4.55 vs Rs 3.65. Standalone revenue Rs 1,274.26 Cr and PAT Rs 223.42 Cr. Board approved Rs 368 Cr capex: Rs 128 Cr to expand Anthraquinone and Carbazole capacity to 5300 MTPA, Rs 70 Cr for Indias first Carbon Nano Tubes facility in West Bengal, and Rs 170 Cr for Super Speciality Carbon Black. All funded via internal accruals.
Strong revenue and profit growth with major capex push into high-value specialty products may support future earnings and margin expansion.